Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WONTECH Receives FDA Clearance for 'HairBoom Air' 2019-10-14 16:47
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal 2019-10-14 14:00
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S. 2019-10-11 13:00
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules 2019-10-11 08:02
111 Unveils New Video on What the Internet Could Do for the Health Management of Aging 2019-10-10 20:31
Volition Appoints Dr. Phillip Barnes to Board of Directors 2019-10-10 04:05
I-Mab Biopharma Receives IND Approval in China for Proprietary CD73 Antibody TJD5 2019-10-04 13:40
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine 2019-10-03 06:30
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US 2019-10-02 12:01
Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval 2019-10-01 04:00
Yuyu Pharma Unveils New Corporate Logo 2019-09-30 21:00
Ascletis Announces Departure of Chief Financial Officer 2019-09-30 16:30
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4 Antagonist) for Locally Advanced Rectal Cancer at ESMO 2019 2019-09-30 13:41
The 10th China (Taizhou) International Medical Expo successfully ended 2019-09-30 13:27
Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019 2019-09-30 06:00
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal 2019-09-30 05:00
From broadcast gymnastics to national fitness 2019-09-29 21:00
CYZone announced "The 2019 Top 50 Healthcare Innovation Enterprises" in China 2019-09-26 21:36
Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications 2019-09-25 18:35
China Biologic Forms Special Committee to Review "Going Private" Proposal 2019-09-24 20:00
1 279 280 281 282 283 800